WebDisclosure WebDisclosure
Basculer en Français
11276 Companies
250575 Keywords
179213 Articles
136416 Press releases
Headlines Articles Press releases BLEECKER Remove
  1. Home
  2. Companies
  3. BLEECKER
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/23/2024 at 19:30, 2 years 5 months ago

    BLEECKER half-year results as of February 29, 2024

    Real Estate Paris Finance Half-year Results BLEECKER
  • PRESS RELEASE

    published on 05/23/2024 at 19:25, 2 years 5 months ago

    Bleecker : RAPPORT FINANCIER SEMESTRIEL AU 29 FEVRIER 2024

    Logo of BLEECKER
  • PRESS RELEASE

    published on 05/23/2024 at 19:25, 2 years 5 months ago

    Bleecker : RESULTATS SEMESTRIELS AU 29 02 2024

    Le Groupe BLEECKER publie ses résultats semestriels au 29 février 2024. Le résultat net s'explique par la variation de la juste valeur des immeubles. Perspectives d'investissement et stratégie de valorisation
    Résultats Semestriels Investissement Immobilier Groupe BLEECKER Juste Valeur Des Immeubles Stratégie De Valorisation
    Logo of BLEECKER
Previous page
1 2 3
Accesswire
  • Published on 11/04/2026 at 23:10, 46 minutes ago

    Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast

  • Published on 11/04/2026 at 23:00, 56 minutes ago

    Avino Reports Q3 2026 Financial Results

  • Published on 11/04/2026 at 23:00, 56 minutes ago

    Viemed Healthcare Announces Third Quarter 2026 Financial Results

  • Published on 11/04/2026 at 22:15, 1 hour 41 minutes ago

    Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity

  • Published on 11/04/2026 at 22:05, 1 hour 51 minutes ago

    Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 11/04/2026 at 19:41, 4 hours 15 minutes ago

    EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026

  • Published on 11/04/2026 at 19:25, 4 hours 31 minutes ago

    Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting

  • Published on 11/04/2026 at 18:43, 5 hours 13 minutes ago

    EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year

  • Published on 11/04/2026 at 18:05, 5 hours 51 minutes ago

    Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

  • Published on 11/04/2026 at 17:40, 6 hours 16 minutes ago

    Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.26.

View all EQS
Les Echos
  • Published on 11/04/2026 at 18:00, 5 hours 56 minutes ago

    The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

  • Published on 11/04/2026 at 18:00, 5 hours 56 minutes ago

    L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms

  • Published on 11/04/2026 at 17:45, 6 hours 11 minutes ago

    October 2026

  • Published on 11/04/2026 at 17:45, 6 hours 11 minutes ago

    Octobre 2026

  • Published on 11/04/2026 at 17:44, 6 hours 12 minutes ago

    Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy